<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02724150</url>
  </required_header>
  <id_info>
    <org_study_id>G2</org_study_id>
    <nct_id>NCT02724150</nct_id>
  </id_info>
  <brief_title>Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding</brief_title>
  <official_title>Low Dose Against High Dose of Proton Pump Inhibitors in Treatment Acute Peptic Ulcer Bleeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Damascus Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Damascus Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the efficacy of Two different regimens of proton pump inhibitors High against Low in
      the management of acute peptic ulcer bleeding
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluate the efficacy of Two different regimens of proton pump inhibitors in the management
      of acute peptic ulcer bleeding First: loading dose 80 mg then 8mg/h iv continuous infusion
      for 3 days Second Loading dose 80 mg the 40 mg every 12 h for 3 days
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    No participants enrolled
  </why_stopped>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rebleeding</measure>
    <time_frame>one month</time_frame>
    <description>recurrent melena (black, tarry stool) or recurrent Hematemesis or coffee-ground emesis or recurrent hematochezia after begin treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgery</measure>
    <time_frame>one month</time_frame>
    <description>need for surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>one month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood transfusions</measure>
    <time_frame>one month</time_frame>
    <description>number of transfusion blood unites during admission</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Gastroduodenal Ulcer</condition>
  <condition>Marginal Ulcer</condition>
  <condition>Peptic Ulcer Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Omeprazole High dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Omeprazole 80 mg loading dose,then 8mg/h IV continuous infusion for 3 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Omeprazole Low Dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Omeprazole 80 mg loading dose IV then 40 mg two times per day IV for 3 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Omeprazole High dose</intervention_name>
    <description>High regimen of Proton Pump Inhibitors in treatment of bleeding ulcer 80 mg loading dose then 8 mg/h iv for 3 days</description>
    <arm_group_label>Omeprazole High dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Omeprazole Low dose</intervention_name>
    <description>low regimen of Proton Pump Inhibitors in treatment bleeding ulcer 80 mg loading dose then 40 mg two times per day for 3 days</description>
    <arm_group_label>Omeprazole Low Dose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  High risk ulcers defined according to the Forrest classification With respect to
             high-risk stigmata,

          -  active bleeding was defined as a continuous blood spurting (Forrest IA)

          -  oozing (Forrest IB) from the ulcer base.

          -  A non-bleeding visible vessel at endoscopy was defined as a discrete protuberance at
             the ulcer base(Forrest IIA).

          -  An adherent clot was one that was resistant to forceful irrigation or suction (Forrest
             IIB).

        Exclusion Criteria:

          -  ulcer was malignant

          -  non ulcerative bleeding such as angiodysplasia , a Mallory-Weiss tear....
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marouf Alhalabi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Damascus Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Damascus Hospital</name>
      <address>
        <city>Damascus</city>
        <zip>+963</zip>
        <country>Syrian Arab Republic</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Syrian Arab Republic</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2016</study_first_submitted>
  <study_first_submitted_qc>March 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2016</study_first_posted>
  <last_update_submitted>January 30, 2018</last_update_submitted>
  <last_update_submitted_qc>January 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gastroduodenal Ulcer</keyword>
  <keyword>Marginal Ulcer</keyword>
  <keyword>Peptic Ulcer Hemorrhage</keyword>
  <keyword>Peptic Ulcer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Peptic Ulcer</mesh_term>
    <mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Omeprazole</mesh_term>
    <mesh_term>Proton Pump Inhibitors</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

